Company Profile
Revolution Medicines Stock Price, News & Analysis
- Ticker:
- RVMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
180.92 USD (-1.60%)
Close
Last updated: July 29, 2026
32.2B USD
Market cap
Why the stock is moving
As of Jul 29, 2026, RVMD closed down 1.60% at $180.92. No new same-company headline was identified in the current news window.
Company overview
Business overview
Revolution Medicines is a RAS-focused oncology company building a platform around RAS-addicted cancers and next-generation inhibitors.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Revolution sits in late-stage oncology biotechnology.
Business Model Characteristics
The company combines clinical development, translational data, and a platform that could support multiple oncology programs.
Position Within the Biotechnology Landscape
Revolution is one of the most watched RAS platform names, and the stock remains highly sensitive to clinical validation.
Future catalysts
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean. The company needs each update to keep proving that the RAS thesis is real.
Recent news
- 01
- 02
- 03
- 04
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Source: Revolution Medicines
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Revolution Medicines (RVMD)?
Revolution Medicines (RVMD) most recently closed at 180.92 USD, a -1.60% move versus the previous session.
What is the market cap of Revolution Medicines (RVMD)?
Revolution Medicines currently has a market capitalization of 32.2B USD on BioPharmSignal.
What does Revolution Medicines do?
Revolution Medicines is a RAS-focused oncology company building a platform around RAS-addicted cancers and next-generation inhibitors.
On which exchange is RVMD stock listed?
Revolution Medicines (RVMD) is associated with NASDAQ, United States, Biopharma.
What is Revolution?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
Which conditions is Revolution Medicines targeting with Revolution?
Revolution Medicines is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Revolution Medicines describe recent progress with Revolution?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
What is Medicines?
Revolution Medicines is a RAS-focused oncology company building a platform around RAS-addicted cancers and next-generation inhibitors.